BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-attraqchi OH, Attimarad M, Venugopala KN, Nair A, Al-attraqchi NH. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives. CPD 2019;25:2716-40. [DOI: 10.2174/1381612825666190716113444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Ding W, Huang W, Zhang Z, Guo Y, Zhang Q, Wu L, Li Y, Qin R, Li J, Shi T, Zhang X, Lei J, Hu W. Discovery of Novel Benzo[4,5]imidazo[1,2-a]pyrazin-1-amine-3-amide-one Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists. J Med Chem 2022. [PMID: 35714367 DOI: 10.1021/acs.jmedchem.2c00101] [Reference Citation Analysis]
2 Du H, Tan Y, Li CH, Zhao Y, Li P, Ning YL, Gao RB, Wang B, Peng Y, Tan SW, Huang ZZ, Chen X, Yang N, Shan FB, Xiong RP, Zhou YG. High glutamate concentration reverses the inhibitory effect of microglial adenosine 2A receptor on NLRP3 inflammasome assembly and activation. Neurosci Lett 2022;769:136431. [PMID: 34974110 DOI: 10.1016/j.neulet.2021.136431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Muzychka LV, Verves EV, Yaremchuk IO, Zinchenko AM, Shishkina SV, Semenyuta IV, Hodyna DM, Metelytsia LO, Kovalishyn V, Smolii OB. Synthesis, QSAR modeling, and molecular docking of novel fused 7-deazaxanthine derivatives as adenosine A2A receptor antagonists. Chem Biol Drug Des 2021. [PMID: 34651417 DOI: 10.1111/cbdd.13975] [Reference Citation Analysis]
4 Li CY, Qin Z, Mei SH, Hu Y, Wu C. A2 adenosine receptor contributes to the development of cow's milk protein allergy via regulating regulatory T cells. Iran J Basic Med Sci 2021;24:1380-7. [PMID: 35096296 DOI: 10.22038/IJBMS.2021.57614.12812] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Matthee C, Terre'Blanche G, Legoabe LJ, Janse van Rensburg HD. Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. Mol Divers 2021. [PMID: 34176057 DOI: 10.1007/s11030-021-10257-9] [Reference Citation Analysis]
6 Reddy GL, Sarma R, Liu S, Huang W, Lei J, Fu J, Hu W. Design, synthesis and biological evaluation of novel scaffold benzo[4,5]imidazo [1,2-a]pyrazin-1-amine: Towards adenosine A2A receptor (A2A AR) antagonist. Eur J Med Chem 2021;210:113040. [PMID: 33316692 DOI: 10.1016/j.ejmech.2020.113040] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Yu F, Zhu C, Xie Q, Wang Y. Adenosine A2A Receptor Antagonists for Cancer Immunotherapy. J Med Chem 2020;63:12196-212. [PMID: 32667814 DOI: 10.1021/acs.jmedchem.0c00237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Varano F, Catarzi D, Vigiani E, Vincenzi F, Pasquini S, Varani K, Colotta V. Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists. Pharmaceuticals (Basel) 2020;13:E161. [PMID: 32722122 DOI: 10.3390/ph13080161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Deb PK. Therapeutic Potentials of Adenosine Receptors: The State of The Art. Curr Pharm Des 2019;25:2789-91. [PMID: 31674891 DOI: 10.2174/138161282526191007143942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bauer EE, Buhr TJ, Reed CH, Clark PJ. Exercise-Induced Adaptations to the Mouse Striatal Adenosine System. Neural Plast 2020;2020:5859098. [PMID: 32399024 DOI: 10.1155/2020/5859098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Deb PK. Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptors. CPD 2019;25:2695-6. [DOI: 10.2174/138161282525190916100149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]